Joseph J Palamar1, Daniel Ciccarone2, Caroline Rutherford3, Katherine M Keyes3, Thomas H Carr4, Linda B Cottler5. 1. New York University Grossman School of Medicine, Department of Population Health, New York, NY, USA. Electronic address: joseph.palamar@nyulangone.org. 2. University of California, San Francisco, Department of Family and Community Medicine, San Francisco, CA, USA. 3. Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, NY, USA. 4. College of Public Affairs, Center for Drug Policy and Prevention, University of Baltimore, United States; Office of National Drug Control Policy, Washington, Baltimore High Intensity Drug Trafficking Areas Program, United States, Center for Drug Policy and Prevention, University of Baltimore, United States. 5. NDEWS, University of Florida, United States; University of Florida, Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, United States.
Abstract
BACKGROUND: Prevalence of fentanyl-laced counterfeit prescription pills has been increasing in the US, possibly placing a wider population at risk for unintentional exposure. We aimed to determine whether there have been shifts in the number of fentanyl seizures and in the form of fentanyl seized in the US. METHODS: We examined quarterly national seizure data from High Intensity Drug Trafficking Areas to determine the number of drug seizures in the US containing fentanyl from January 2018 through December 2021. Generalized additive models were used to estimate trends in the number and weight of pill and powder seizures containing fentanyl. RESULTS: There was an increase both in the number of fentanyl-containing powder seizures (from 424 in 2018 Quarter 1 [Q1] to 1539 in 2021 Quarter 4 [Q4], β = 0.94, p < 0.001) and in the number of pill seizures (from 68 to 635, β = 0.96, p < 0.01). The proportion of pills to total seizures more than doubled from 13.8% in 2018 Q1 to 29.2% in 2021 Q4 (β = 0.92, p < 0.001). Weight of powder fentanyl seizures increased from 298.2 kg in 2018 Q1 to 2416.0 kg in 2021 Q4 (β = 1.12, p = 0.01); the number of pills seized increased from 42,202 in 2018 Q1 to 2,089,186 in 2021 Q4 (β = 0.90, p < 0.001). CONCLUSIONS: Seizures of drugs containing fentanyl have been increasing in the US. Given that over a quarter of fentanyl seizures are now in pill form, people who obtain counterfeit pills such as those disguised as oxycodone or alprazolam are at risk for unintentional exposure to fentanyl.
BACKGROUND: Prevalence of fentanyl-laced counterfeit prescription pills has been increasing in the US, possibly placing a wider population at risk for unintentional exposure. We aimed to determine whether there have been shifts in the number of fentanyl seizures and in the form of fentanyl seized in the US. METHODS: We examined quarterly national seizure data from High Intensity Drug Trafficking Areas to determine the number of drug seizures in the US containing fentanyl from January 2018 through December 2021. Generalized additive models were used to estimate trends in the number and weight of pill and powder seizures containing fentanyl. RESULTS: There was an increase both in the number of fentanyl-containing powder seizures (from 424 in 2018 Quarter 1 [Q1] to 1539 in 2021 Quarter 4 [Q4], β = 0.94, p < 0.001) and in the number of pill seizures (from 68 to 635, β = 0.96, p < 0.01). The proportion of pills to total seizures more than doubled from 13.8% in 2018 Q1 to 29.2% in 2021 Q4 (β = 0.92, p < 0.001). Weight of powder fentanyl seizures increased from 298.2 kg in 2018 Q1 to 2416.0 kg in 2021 Q4 (β = 1.12, p = 0.01); the number of pills seized increased from 42,202 in 2018 Q1 to 2,089,186 in 2021 Q4 (β = 0.90, p < 0.001). CONCLUSIONS: Seizures of drugs containing fentanyl have been increasing in the US. Given that over a quarter of fentanyl seizures are now in pill form, people who obtain counterfeit pills such as those disguised as oxycodone or alprazolam are at risk for unintentional exposure to fentanyl.
Authors: Patil Armenian; Alexander Olson; Andres Anaya; Alicia Kurtz; Rawnica Ruegner; Roy R Gerona Journal: Ann Emerg Med Date: 2016-07-26 Impact factor: 5.721
Authors: Sean Esteban McCabe; Christian J Teter; Carol J Boyd; Timothy E Wilens; Ty S Schepis Journal: J Clin Psychiatry Date: 2018 Mar/Apr Impact factor: 4.384
Authors: Tibor M Brunt; Constanze Nagy; Alexander Bücheli; Daniel Martins; Miren Ugarte; Cécile Beduwe; Mireia Ventura Vilamala Journal: Drug Test Anal Date: 2016-02-17 Impact factor: 3.345
Authors: Linda B Cottler; Bruce A Goldberger; Sara Jo Nixon; Catherine W Striley; Elan Barenholtz; Nicole D Fitzgerald; Sean M Taylor; Joseph J Palamar Journal: Drug Alcohol Depend Date: 2020-09-14 Impact factor: 4.492
Authors: Joseph J Palamar; Linda B Cottler; Bruce A Goldberger; Stevan Geoffrey Severtson; David J Grundy; Janetta L Iwanicki; Daniel Ciccarone Journal: Am J Drug Alcohol Abuse Date: 2022-06-15 Impact factor: 3.912
Authors: Sarah S Shin; Kate LaForge; Erin Stack; Justine Pope; Gillian Leichtling; Jessica E Larsen; Judith M Leahy; Andrew Seaman; Daniel Hoover; Laura Chisholm; Christopher Blazes; Robin Baker; Mikaela Byers; Katie Branson; P Todd Korthuis Journal: Harm Reduct J Date: 2022-07-11